Approval and Endorsement
In 1997, the United States Food and Drug Administration (FDA) approved the use of VNS as an adjunctive therapy for partial-onset epilepsy. In 2005, the FDA approved the use of VNS for treatment-resistant depression.
Although the use of VNS for refractory depression has been endorsed by the American Psychiatric Association, the FDA's approval of VNS for refractory depression remains controversial. According to Dr. A. John Rush, vice chairman for research in the Department of Psychiatry at the University of Texas Southwestern Medical Center at Dallas, results of the VNS pilot study showed that 40 percent of the treated patients displayed at least a 50 percent or greater improvement in their condition, according to the Hamilton Depression Rating Scale. Many other studies concur that VNS is indeed efficacious in treating depression. However, these findings do not take into account improvements over time in patients without the device. In the only randomized controlled trial VNS failed to perform any better when turned on than in otherwise similar implanted patients whose device was not turned on.
Read more about this topic: Vagus Nerve Stimulation
Famous quotes containing the word approval:
“You know that your toddler needed love and approval but he often seemed not to care whether he got it or not and never seemed to know how to earn it. Your pre-school child is positively asking you to tell him what does and does not earn approval, so he is ready to learn any social refinement of being human which you will teach him....He knows now that he wants your love and he has learned how to ask for it.”
—Penelope Leach (20th century)